Fibroblast cytoskeletal remodeling contributes to connective tissue tension

Department of Neurology, University of Vermont, Burlington, Vermont 05405, USA.
Journal of Cellular Physiology (Impact Factor: 3.84). 05/2011; 226(5):1166-75. DOI: 10.1002/jcp.22442
Source: PubMed

ABSTRACT The visco-elastic behavior of connective tissue is generally attributed to the material properties of the extracellular matrix rather than cellular activity. We have previously shown that fibroblasts within areolar connective tissue exhibit dynamic cytoskeletal remodeling within minutes in response to tissue stretch ex vivo and in vivo. Here, we tested the hypothesis that fibroblasts, through this cytoskeletal remodeling, actively contribute to the visco-elastic behavior of the whole tissue. We measured significantly increased tissue tension when cellular function was broadly inhibited by sodium azide and when cytoskeletal dynamics were compromised by disrupting microtubules (with colchicine) or actomyosin contractility (via Rho kinase inhibition). These treatments led to a decrease in cell body cross-sectional area and cell field perimeter (obtained by joining the end of all of a fibroblast's processes). Suppressing lamellipodia formation by inhibiting Rac-1 decreased cell body cross-sectional area but did not affect cell field perimeter or tissue tension. Thus, by changing shape, fibroblasts can dynamically modulate the visco-elastic behavior of areolar connective tissue through Rho-dependent cytoskeletal mechanisms. These results have broad implications for our understanding of the dynamic interplay of forces between fibroblasts and their surrounding matrix, as well as for the neural, vascular, and immune cell populations residing within connective tissue.

Download full-text


Available from: James C Iatridis, Oct 15, 2014
66 Reads
  • Source
    • "Importantly, this change in fibroblast shape is accompanied by a lowering of connective tissue tension [Langevin et al., 2011]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The biomechanical behavior of connective tissue in response to stretching is generally attributed to the molecular composition and organization of its extracellular matrix. It also is becoming apparent that fibroblasts play an active role in regulating connective tissue tension. In response to static stretching of the tissue, fibroblasts expand within minutes by actively remodeling their cytoskeleton. This dynamic change in fibroblast shape contributes to the drop in tissue tension that occurs during viscoelastic relaxation. We propose that this response of fibroblasts plays a role in regulating extracellular fluid flow into the tissue, and protects against swelling when the matrix is stretched. This article reviews the evidence supporting possible mechanisms underlying this response including autocrine purinergic signaling. We also discuss fibroblast regulation of connective tissue tension with respect to lymphatic flow, immune function and cancer. J. Cell. Biochem. © 2013 Wiley Periodicals, Inc.
    Journal of Cellular Biochemistry 08/2013; 114(8). DOI:10.1002/jcb.24521 · 3.26 Impact Factor
  • Source
    • "Fibroblasts in culture and in vivo respond to mechanical loads with measurable effects, such as extracellular calcium influx (through stretch-activated membrane channels), calcium-induced release of intracellular calcium stores, and the release of ATP. These studies indicate that tissue contraction and relaxation may result in a dynamic, body-wide pattern of cellular activity (Langevin et al., 2011, 2010). Furthermore the morphology of the embedded fibroblast changes from lamellar to dendritic, depending on the tensional status of the fascial network (Grinnell, 2000, 2007, 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: More than 100 years ago AT Still MD founded osteopathic medicine, and specifically described fascia as a covering, with common origins of layers of the fascial system despite diverse names for individual parts. Fascia assists gliding and fluid flow and is highly innervated. Fascia is intimately involved with respiration and with nourishment of all cells of the body, including those of disease and cancer. This paper reviews information presented at the first three International Fascia Research Congresses in 2007, 2009 and 2012 from the perspective of Dr Still, that fascia is vital for organism's growth and support, and it is where disease is sown.
    Journal of bodywork and movement therapies 07/2013; 17(3):356-64. DOI:10.1016/j.jbmt.2013.05.015
  • Source
    • "Tissue stiffness is implicated in many crucial physiological and pathological conditions, such as development, tumorigenesis, wound healing and fibrosis [33], [34],[35]. Tissue stiffness is primarily decided by two factors, thus ECM rigidity and contractile force generated by stromal cells [36], [37]. Lumican can bind with collagen fibril, the major ECM structure components, and regulate its assembly [38],which might affect ECM rigidity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Lumican is a dermatan sulfate proteoglycan highly expressed in connective tissue and has the ability to regulate collagen fibril assembly. Previous studies have shown that lumican is involved in wound healing, but the precise effects of lumican on reepithelialization and wound contraction, the two pivotal aspects of skin wound healing, have not been investigated. Here we explored the roles of lumican in fibroblast contractility, a main aspect of skin wound healing, by adopting mice skin wound healing model and the corresponding in vitro cellular experiments. Our results showed that lumican can promote skin wound healing by facilitating wound fibroblast activation and contraction but not by promoting keratinocyte proliferation and migration. Silencing of integrin α2 completely abolished the pro-contractility of lumican, indicating lumican enhances fibroblast contractility via integrin α2. Our study for the first time demonstrated that lumican can affect fibroblast's mechanical property, which is pivotal for many important pathological processes, such as wound healing, fibrosis, and tumor development, suggesting that lumican might have a potential to be used to modulate these processes.
    PLoS ONE 06/2013; 8(6):e67124. DOI:10.1371/journal.pone.0067124 · 3.23 Impact Factor
Show more